TARS

NASDAQ · Pharmaceuticals

Tarsus Pharmaceuticals Inc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$67.45

-1.62 (-2.35%)

As of Nov 5, 8:41 PM ET ·

TARS News1 articles

Tarsus Surges 9% as Alkeus Deal Value Climbs to $536M

Tarsus shares rose 9.1% after closing the Alkeus acquisition, boosting the upfront package's market value to $536 million. Key clinical data expected in 2029.